Clinical Trials Logo

At Risk Mental State (ARMS) clinical trials

View clinical trials related to At Risk Mental State (ARMS).

Filter by:
  • None
  • Page 1

NCT ID: NCT03369730 Completed - Clinical trials for First Episode Psychosis (FEP)

Reducing the Duration of Untreated Psychosis in the United States

Start date: February 19, 2018
Phase:
Study type: Observational

The goal of this project is to investigate whether a systematic screening approach for individuals with first episode psychosis (FEP) can substantially reduce Duration of Untreated Psychosis (DUP). The study team will evaluate the feasibility of screening a consecutive help-seeking population entering mental health services in order to facilitate early identification of FEP cases, rapid referral to specialty care and engagement in treatment.

NCT ID: NCT02569307 Completed - Psychosis Clinical Trials

Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States

NAYAB
Start date: October 2015
Phase: Phase 2
Study type: Interventional

This is a randomized double-blind placebo controlled trial which aims to evaluate the efficacy and tolerability of minocycline and Omega-3 fatty acids for patients with ARMS. Specifically to determine whether the addition of minocycline and / or Omega-3 fatty acids to Treatment as Usual in an operationalized ARMS population in Pakistan: